Thursday, June 4, 2020
Home Tags Betagenon AB

Tag: betagenon AB

AMPK activator O304 – a novel treatment for Type 2 diabetes and diabetic kidney disease

AMPK activator O304 – a novel treatment for Type 2 diabetes and diabetic kidney...

The high and increasing unmet patient need in diabetic kidney disease demands new drugs. Betagenon AB has the answer. Globally, approximately 40% of Type 2...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest